Clinical Trial

124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome

Enrolling by Invitation Phase 2
View on ClinicalTrials.gov →
Summary
This clinical trial will use the amyloid-binding radiotracer, 124I-evuzamitide, to potentially detect amyloid, in the heart and elsewhere, in patients who have a history of lumbar spinal stenosis and/or carpal tunnel syndrome.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-26; most recent amendment 2026-07-17.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-05-13
Trial Details
NCT Number NCT06907849
Lead Sponsor University of Tennessee Graduate School of Medicine
Collaborators: Attralus, Inc.
Conditions Lumbar Spinal Stenosis, Carpal Tunnel Syndrome (CTS), Cardiac Amyloidosis
Enrollment 40 participants
Start Date 2025-05-22
Primary Completion 2027-03 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-21